Off Label Use of Eltrombopag and Recombinant Activated Factor VII in Wiskott-Aldrich Syndrome. A Case Report and Review of Literature

• Autores principales: Alkistis Adramerina (Autor), Nancy Chainoglou (Autor), Stamatia Theodoridou (Autor), Aikaterini Teli (Autor), Marina Economou (Autor)
• Formato: Libro
• Publicado: The Korean Society of Pediatric Hematology-Oncology, 2022-04-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Wiskott-Aldrich syndrome (WAS) is characterized by eczema, recurrent infections and microthrombocytopenia, with the latter being the most consistent finding in the course of the disease. The present case report describes a pediatric patient with WAS and severe bleeding phenotype resulting from a ver...